Evidence map›Paper›PMID 31862950›Full record

ArticleNature communications2019

Relationship between gut microbiota and circulating metabolites in population-based cohorts.

Dina Vojinovic, Djawad Radjabzadeh, Alexander Kurilshikov, Najaf Amin, Cisca Wijmenga, Lude Franke, M Arfan Ikram, Andre G Uitterlinden, Alexandra Zhernakova, Jingyuan Fu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 2 syntheses or guidelines pooled it, 256 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Gut microbial alterations and functional shifts in patients with hypertriglyceridemia: insights from a northwestern Chinese metagenomic study.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  9. Article
  10. Recent Trends in Metabolomics by NMR Spectroscopy.Angewandte Chemie (International ed. in English) · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The Gut Microbiome and Metabolomics Profiles of Dust-exposed Rats.Combinatorial chemistry & high throughput screening · 2026
    Article
  18. Review
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Dina VojinovicDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. d.vojinovic@erasmusmc.nl.
Djawad RadjabzadehDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Alexander KurilshikovUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-2541-5627
Najaf AminDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Cisca WijmengaUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.ORCID http://orcid.org/0000-0002-5635-1614
Lude FrankeUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
M Arfan IkramDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0372-8585
Andre G UitterlindenDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-7276-3387
Alexandra ZhernakovaUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Jingyuan FuUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Robert KraaijDepartment of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Cornelia M van DuijnDepartment of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Cornelia.vanDuijn@ndph.ox.ac.uk.
Erasmus MC · NLUniversity Medical Center Groningen · NL

Funding

Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-ADU01AG061359 · NIA · DUKE UNIVERSITY · PI KADDURAH-DAOUK, RIMA F, KASTENMULLER, GABI · 2018 to 2022
$10.0M
NIA NIH HHS U01 AG061359
6 · The paper itself

Abstract

Gut microbiota has been implicated in major diseases affecting the human population and has also been linked to triglycerides and high-density lipoprotein levels in the circulation. Recent development in metabolomics allows classifying the lipoprotein particles into more details. Here, we examine the impact of gut microbiota on circulating metabolites measured by Nuclear Magnetic Resonance technology in 2309 individuals from the Rotterdam Study and the LifeLines-DEEP cohort. We assess the relationship between gut microbiota and metabolites by linear regression analysis while adjusting for age, sex, body-mass index, technical covariates, medication use, and multiple testing. We report an association of 32 microbial families and genera with very-low-density and high-density subfractions, serum lipid measures, glycolysis-related metabolites, ketone bodies, amino acids, and acute-phase reaction markers. These observations provide insights into the role of microbiota in host metabolism and support the potential of gut microbiota as a target for therapeutic and preventive interventions.

Indexed as

Acute-Phase ProteinsAdultAmino AcidsBacteriaCohort StudiesDNA, BacterialFecesFemaleGastrointestinal MicrobiomeGlycolysisHost Microbial InteractionsHumansLipoproteins, HDLMaleMetabolomeMetabolomicsAcute-Phase ProteinsAmino AcidsDNA, BacterialLipoproteins, HDLRNA, Ribosomal, 16STriglycerides

Identifiers

PMID31862950
PMCPMC6925111
OpenAlexW2995983288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.